NONE

Company

Quince Therapeutics, Inc.

Filed

July 17, 2023

Accession Number

0001567619-23-006604

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →